Percutaneous revascularization of grafts versus native coronary arteries in postcoronary artery bypass graft patients

Area of Science:

• Cardiology
• Interventional Cardiology
• Vascular Surgery

Background:

• Coronary artery bypass graft (CABG) surgery is a common treatment for coronary artery disease.
• The long-term efficacy of percutaneous interventions on grafts versus native arteries remains unclear.
• Optimal revascularization strategies in patients with prior CABG are essential for improved patient outcomes.

Purpose of the Study:

• To compare the clinical outcomes of percutaneous interventions performed on coronary artery bypass grafts versus native arteries.
• To evaluate procedural success rates, major adverse events, mortality, and target-lesion revascularization between the two groups.

Main Methods:

• A comparative study involving 84 patients who underwent percutaneous interventions.
• Patients were divided into two groups: those receiving interventions on grafts (n=31) and those on native arteries (n=53).
• Clinical outcomes were assessed up to a mean follow-up of 19 months.

Main Results:

• Procedural success rates were high and similar in both groups (96.8% graft vs 94.4% native, P=.3).
• Major adverse events (12.9% graft vs 15.1% native, P=.8) and mortality rates (6.4% graft vs 1.8% native, P=.3) were comparable.
• Target-lesion revascularization rates were low and similar (6.4% graft vs 3.7% native, P=.6).

Conclusions:

• Percutaneous interventions on both coronary artery bypass grafts and native arteries yield similar immediate and midterm clinical outcomes.
• Both strategies demonstrate a low risk of target-lesion revascularization, offering encouraging results.
• These findings suggest that graft or native percutaneous interventions can be considered equivalent in terms of clinical efficacy and safety.